News Focus
News Focus
Followers 24
Posts 4176
Boards Moderated 0
Alias Born 12/18/2019

Re: X Master post# 522689

Tuesday, 10/18/2022 12:41:49 AM

Tuesday, October 18, 2022 12:41:49 AM

Post# of 822740
Considering Optune has been approved and achieved 13% survival rate in 5 years similar to what DCVax-L is currently trying to report. UK regulators will see the same benefit, then it is pricing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News